Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation in cutaneous malignant melanoma outcome
2012-002125-30Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vitamin d in melanoma, sponsored by UZ Leuven. Primary endpoint: Relapse free survival. Started Aug 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
melanoma
Beyond the preview
Go deeper on 2012-002125-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002125-30.